10-Q: Centene Corporation Reports First Quarter 2024 Results, Navigates Medicaid Redeterminations and Strategic Divestitures

Centene Corporation's first quarter 2024 results show revenue growth and strategic adjustments amidst Medicaid redeterminations and divestitures.

Summary

• Centene Corporation reported a 4% increase in total revenues to $40.4 billion for the first quarter of 2024, compared to the same period in 2023.
• Premium and service revenues also saw a 4% increase year-over-year, reaching $36.3 billion.
• The company's health benefits ratio (HBR) was 87.1%, slightly up from 87.0% in the first quarter of 2023.
• Selling, general, and administrative (SG&A) expenses increased to 8.9% of premium and service revenues, compared to 8.6% in the prior year.
• Adjusted diluted earnings per share (EPS) were $2.26, compared to $2.11 in the first quarter of 2023.
• The company experienced a decrease in managed care membership by 33,000 members, or 0.1%, year-over-year, primarily due to Medicaid redeterminations.
• Operating cash flows used cash of $456 million in the first quarter of 2024, influenced by timing of payments and the PBM transition.
• Centene completed the divestitures of Operose Health Group and Circle Health during the quarter.

Sentiment

Score: 6

Explanation: The document presents a mixed picture with positive revenue growth and strategic actions, but also challenges related to membership, costs, and regulatory changes. The sentiment is cautiously optimistic, reflecting the company's efforts to navigate a complex environment.

Positives

• Centene's Marketplace business saw significant growth, with a 41% increase in membership.
• The company successfully commenced new Medicaid contracts in Nebraska and California.
• The company is actively engaged in helping individuals maintain Medicaid coverage or find alternative options during redeterminations.
• The company's Medicare PDP membership saw a substantial increase.
• Centene is implementing a multi-year plan to improve quality across the enterprise with a focus on patient experience and access to care.

Negatives

• Managed care membership decreased slightly by 0.1% year-over-year, primarily due to Medicaid redeterminations.
• Medicare Advantage membership declined year-over-year.
• The company's Star quality ratings decreased, negatively impacting 2024 Medicare revenue.
• Operating cash flows were negative at $456 million for the quarter.
• The company recorded a $14 million impairment charge related to Health Net Federal Services assets.

Risks

• Medicaid redeterminations are expected to continue through the second quarter of 2024, potentially impacting membership.
• Changes in CMS regulations may restrict product offerings in some geographic service areas.
• The company faces risks related to competition, contract reprocurements, and organic growth.
• There are uncertainties concerning government shutdowns, debt ceilings, or funding.
• The company is subject to legal and regulatory proceedings, which could result in substantial damages, fines, or penalties.
• The company's investment portfolio is subject to market risks, including interest rate fluctuations.

Future Outlook

Centene expects to receive net dividends of approximately $2.9 billion from its insurance subsidiaries and spend approximately $450 million in additional capital expenditures during the remainder of 2024. The company believes its available cash, cash equivalents, investments, and cash from operations will be sufficient to finance its general operations and capital expenditures for at least 12 months from the date of the filing.

Management Comments

• The company remains focused on delivering access to high-quality, affordable healthcare to all of its members.
• Centene believes it is well-positioned to meet the needs of the changing healthcare landscape.
• The company is committed to navigating evolving regulations.
• Centene is actively engaged to help ensure individuals take the state agency requested action to confirm eligibility in their Medicaid coverage or find other appropriate coverage.
• The company is advocating for and seeing adoption of coverage expansions for Medicaid adult populations, postpartum, foster care, and children.
• Centene continues the use of data and analytics to optimize its business.
• The company believes it has both the capacity and capability to successfully navigate industry changes to the benefit of its members, customers, providers, and shareholders.

Industry Context

Centene's performance is being influenced by broader industry trends such as Medicaid redeterminations, changes in government healthcare programs, and the increasing importance of quality ratings in Medicare. The company's strategic divestitures and focus on core businesses reflect a trend towards streamlining operations and improving profitability in the healthcare sector. The expansion of the Health Insurance Marketplace product aligns with the industry's focus on providing affordable healthcare options.

Comparison to Industry Standards

• Centene's HBR of 87.1% is within the typical range for managed care organizations, but the slight increase year-over-year indicates potential challenges in managing medical costs.
• The SG&A expense ratio of 8.9% is higher than some peers, reflecting the company's investment in growth areas like the Marketplace business.
• The 44% increase in Medicare PDP membership is a positive sign, but the decline in Medicare Advantage membership highlights the impact of lower Star ratings, which is a common challenge in the industry.
• The company's strategic divestitures are similar to actions taken by other large healthcare companies to focus on core businesses and improve financial performance.
• Centene's efforts to improve Star ratings and enhance patient experience are consistent with industry-wide initiatives to improve quality and outcomes.

Legal Proceedings

• The Company is routinely subjected to legal and regulatory proceedings in the normal course of business.
• These matters can include, without limitation: periodic compliance and other reviews and investigations by various federal and state regulatory agencies; litigation arising out of general business activities; and disputes regarding reinsurance arrangements, claims arising out of the acquisition or divestiture of various assets, class actions and claims relating to the performance of contractual and non-contractual obligations to providers, members, employer groups, vendors and others.
• The Company intends to vigorously defend itself against legal and regulatory proceedings to which it is currently a party; however, these proceedings are subject to many uncertainties.
• In some of the cases pending against the Company, substantial non-economic or punitive damages are being sought.
• The Company records reserves and accrues costs for certain legal proceedings and regulatory matters to the extent that it determines an unfavorable outcome is probable and the amount of the loss can be reasonably estimated.
• As of the date of this report, amounts accrued for legal proceedings and regulatory matters were not material, except for the reserve estimate as previously disclosed in the Company's 2023 Annual Report on Form 10-K with respect to claims or potential claims involving services provided by Envolve Pharmacy Solutions, Inc. (Envolve), as the Company's pharmacy benefits management (PBM) subsidiary.

Stakeholder Impact

• Shareholders may be impacted by the company's financial performance, strategic decisions, and stock repurchases.
• Employees may be affected by restructuring efforts and changes in compensation.
• Members may experience changes in coverage and access to care due to Medicaid redeterminations and other regulatory changes.
• Providers may be impacted by changes in contracts and reimbursement rates.
• Customers may be affected by changes in product offerings and service delivery.

Next Steps

• Centene will continue to manage Medicaid redeterminations and assist members in maintaining coverage.
• The company will focus on improving its Medicare Star quality ratings.
• Centene will continue to implement its Value Creation Plan.
• The company will monitor state legislation and advocate for coverage expansions.
• Centene will continue to evaluate refinancing opportunities.

Key Dates

Keywords

Medicaid, Medicare, Health Insurance Marketplace, Ambetter Health, Managed Care, Redeterminations, Divestitures, Star Ratings, Premium Revenue, Membership, Healthcare, PBM